Advertisement

Letter from the Editor

Letter from the Editor

A special message from Jonathan Adler, MD
Clinical Strategy Editor, NEJM Group

Journal Watch has some exciting new developments to share. Recently, we announced the news that we have created NEJM Group to bring you medical knowledge in new ways and to support a broader, global health care community.

As a premier product within NEJM Group, Journal Watch now has a new name — NEJM Journal Watch.  We are also introducing richer content, with enhanced graphics and the new, mobile-optimized website you’re now visiting that offers simpler navigation and more information about our physician-editors.

As NEJM Journal Watch, we remain committed to delivering an independent perspective on critical advances in clinical medicine. NEJM Group Editor-in-Chief Jeffrey M. Drazen, MD, says:

"We are providing you with the information you need to do your job in the best way possible. We know how important having trusted sources on new developments is for providing good patient care, and we are committed to maintaining the independence and integrity of NEJM Journal Watch."

Every day, busy clinicians across the globe turn to our editorial board of thought leaders for expert research summaries and perspectives that help them be clinically prepared and confident.

I invite you to explore our new site and see how we’ve enhanced the value of the clinical information you need.  We hope you enjoy the new NEJM Journal Watch!

Explore JWatch.org